Edgewell Personal Care AI Stock Analysis
Want to see EPC full AI Analyst Report?
Edgewell Personal Care (EPC) AI Stock Analysis
Edgewell Personal Care
(NYSE:EPC)
The score is held back primarily by weakened financial performance—especially the sharp drop in operating cash flow and negative free cash flow alongside a 2026 net loss. Technicals are a relative positive with the stock trading above key moving averages and positive MACD momentum. Earnings call guidance supports a recovery narrative (margin and cash flow improvement in fiscal 2027), but execution risks (Wet Shave consolidation delays, inflation/tariffs, restructuring charges) and loss-based valuation uncertainty keep the overall score in the mid-range.
Edgewell Personal Care Key Performance Indicators (KPIs)
Operating Income by SegmentReports operating profit for each segment, revealing which businesses generate sustainable profits after costs, which dilute margins, and where management should prioritize cost control or capital allocation to improve overall profitability.
Profitability is being reshaped: Wet Shave remains the clear earnings engine but shows seasonal volatility and some North America pressure, Sun & Skin swings from loss to strong recovery (seasonal Sun Care and marketing-driven), and Feminine Care income drops to zero after the divestiture—which reduced near-term operating income but improved balance sheet and funded debt paydown. Corporate costs and one-time execution/transition expenses have pushed corporate losses wider this year; management’s productivity programs and H2 marketing investments point to margin recovery, but expect near-term earnings compression and lumpy improvement into FY27–FY28.
Edgewell Personal Care (EPC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.26B
- Dividend Yield
- 2.20%
- Average Volume (3M)
- 539.63K
- Price to Earnings (P/E)
- -24.6
- Beta (1Y)
- 0.31
- Revenue Growth
- -10.21%
- EPS Growth
- -310.40%
- Country
- US
- Employees
- 6,500
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Edgewell Personal Care Business Overview & Revenue Model
Company Description
Edgewell Personal Care Company, along with its associated businesses, is a global producer and distributor of a diverse range of personal care items. The company organizes its operations into three main divisions: Wet Shave, Sun and Skin Care, and Fe...
How the Company Makes Money
Edgewell makes money by selling personal care products to retailers and distributors (and via e-commerce) under a portfolio of consumer brands, generating revenue primarily from product sales volumes multiplied by negotiated wholesale prices, net of...
Edgewell Personal Care Earnings Call Summary
The call was predominantly positive. Management highlighted a return to organic sales growth, stronger fourth-quarter margins and earnings, improved North American and international momentum, broad share gains, strong performance from Cremo and Hawaiian Tropic, and a broad fiscal 2027 innovation and transformation plan. These positives were tempered by Wet Shave supply constraints, the delayed manufacturing consolidation savings, fiscal-year operating profit and cash flow declines, inflation and tariff pressures, the loss of TSA income, restructuring charges and near-term first-quarter pressure.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For fiscal '27, Edgewell expects organic net sales growth between 1% and 3%, with growth in both International and North America, International organic growth at mid-single-digit organic growth, and currency a 60 basis point headwind to reported net sales; Q1 organic net sales are expected to be flat to down approximately 1%. Adjusted gross margin is expected to expand approximately 60 basis points, adjusted SG&A to improve 90 basis points as a rate of sales, adjusted operating profit to grow by approximately 10%, and adjusted operating profit margin to increase approximately 70 basis points, while A&P is expected to rise about 80 basis points to approximately 13% of net sales, including approximately 14% of net sales in Q1. Adjusted EPS is expected to be $1.85 to $2.15 per share, growing approximately 3.5% at the midpoint, with approximately $0.20 of expected headwinds below operating profit, including $0.17 from the expiration of TSA income and $0.03 from a higher effective tax rate of approximately 24%, up about 1 point from fiscal '26; adjusted EBITDA is expected to be $250 million to $270 million, approximately 2% growth to prior year at the midpoint, absorbing approximately $11 million of TSA income, and adjusted free cash flow is expected to be $100 million to $120 million. The company expects 2/3 of adjusted EBITDA and approximately 80% of adjusted EPS in the second half, approximately 300 basis points of overall inflation, well over 250 basis points of productivity and volume absorption, and restructuring and related charges of approximately $55 million in fiscal '27.
Edgewell Personal Care Financial Statement Overview
Summary
Overall fundamentals have weakened: revenue declined into 2026, margins compressed, and the year swung to a net loss. Cash generation is the biggest issue—operating cash flow dropped sharply and free cash flow turned negative—reducing flexibility. The balance sheet is serviceable with moderate leverage and improved debt-to-equity versus 2025, but the loss-driven negative ROE raises execution risk until profitability and cash conversion recover.
Income Statement
44NeutralBalance Sheet
58NeutralCash Flow
36Negative| Breakdown | TTM | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.00B | 2.00B | 2.22B | 2.25B | 2.25B | 2.17B |
| Gross Profit | 838.70M | 830.00M | 924.90M | 955.70M | 940.80M | 880.50M |
| EBITDA | 126.50M | 145.90M | 185.60M | 285.40M | 317.60M | 285.40M |
| Net Income | -51.70M | -51.70M | 25.40M | 98.60M | 114.70M | 99.50M |
Balance Sheet | ||||||
| Total Assets | 3.55B | 3.55B | 3.76B | 3.73B | 3.74B | 3.71B |
| Cash, Cash Equivalents and Short-Term Investments | 375.60M | 375.60M | 225.70M | 209.10M | 216.40M | 188.70M |
| Total Debt | 1.28B | 1.28B | 1.54B | 1.39B | 1.45B | 1.46B |
| Total Liabilities | 2.08B | 2.08B | 2.20B | 2.15B | 2.20B | 2.25B |
| Stockholders Equity | 1.47B | 1.47B | 1.55B | 1.58B | 1.54B | 1.47B |
Cash Flow | ||||||
| Free Cash Flow | -10.00M | -10.00M | 41.40M | 174.50M | 166.60M | 45.60M |
| Operating Cash Flow | 49.60M | 49.60M | 118.40M | 231.00M | 216.10M | 102.00M |
| Investing Cash Flow | 289.20M | 289.20M | -72.90M | -62.40M | -50.50M | -355.40M |
| Financing Cash Flow | -182.80M | -182.80M | -30.00M | -179.40M | -146.50M | -17.60M |
Edgewell Personal Care Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Negative. The current price of 27.28 is below the 20-day moving average (MA) of 28.38, below the 50-day MA of 27.82, and above the 200-day MA of 24.21, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 43.87 is Neutral, neither overbought nor oversold. The STOCH value of 35.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EPC.
Edgewell Personal Care Risk Analysis
Edgewell Personal Care disclosed 28 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.
Latest Risks Added
3 New RisksEdgewell Personal Care Peers Comparison
Overall Rating
CHD78Outperform
PG72Outperform
UL64Neutral
HELE55Neutral
EPC54Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | $26.67B | 34.66 | 18.21% | 1.09% | 1.70% | 2.07% | |
| 72Outperform | $393.56B | 25.16 | 29.55% | 2.55% | 3.52% | -3.74% | |
| 64Neutral | $141.97B | 14.06 | 58.26% | 3.25% | -17.45% | 8.84% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 55Neutral | $872.94M | -8.58 | -11.86% | ― | 0.52% | 84.94% | |
| 54Neutral | $1.26B | -24.58 | -3.53% | 2.20% | -10.21% | -310.40% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| EPC | Edgewell Personal Care Co | 27.28 | 9.98 | 57.68% | |
| CHD | Church & Dwight Company | 113.00 | 30.98 | 37.77% | |
| HELE | Helen Of Troy | 37.32 | 19.77 | 112.65% | |
| PG | Procter & Gamble Company | 169.80 | 28.09 | 19.82% | |
| UL | Unilever plc | 66.21 | 4.85 | 7.90% |
Edgewell Personal Care Corporate Events
Edgewell Reassigns LaTanya Langley to New Leadership Role
NeutralOn September 17, 2026, Edgewell Personal Care Company announced that LaTanya Langley will transition to the newly defined role of Chief Administrative and Legal Officer and Corporate Secretary, effective October 1, 2026, reflecting a reallocation of...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026
